CSat Investment Advisory’s Abiomed Inc ABMD Stock Holding History

CSat Investment Advisory’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$63K	Buy	197 +6	+3%	+$1.92K	0.05%	145
2020 Q4	$62K	Sell	191 -150	-44%	-$41.5K	0.06%	123
2020 Q3	$95K	Buy	341 +1	+0.3%	+$288	0.01%	484
2020 Q2	$82K	Sell	340 -154	-31%	-$30.9K	0.01%	545
2020 Q1	$72K	Buy	494 +72	+17%	+$12K	0.02%	429
2019 Q4	$72K	Buy	422 +78	+23%	+$14.5K	0.02%	477
2019 Q3	$61K	Buy	344 +108	+46%	+$23.3K	0.02%	439
2019 Q2	$62K	Buy	236 +174	+281%	+$46.2K	0.02%	407
2019 Q1	$18K	Buy	62 +8	+15%	+$2.66K	0.01%	340
2018 Q4	$18K	Buy	54 +22	+69%	+$7.64K	0.01%	317
2018 Q3	$14K	Buy	32 +8	+33%	+$3.15K	0.01%	305
2018 Q2	$10K	Buy	+24	New	+$8.7K	0.01%	361

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CSat Investment Advisory's ABMD Position: Q1 2021 in Review

CSat Investment Advisory increased its Abiomed Inc (ABMD) stake by 3.1% in Q1 2021, buying an estimated $1.92K and bringing the position to 197 shares worth $63K. The position accounts for 0.05% of the portfolio, ranked #145.

CSat Investment Advisory first reported a position in ABMD in Q2 2018 and has held it in 12 quarters since. The position peaked at $95K in Q3 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

CSat Investment Advisory held 197 shares of Abiomed Inc worth $63K as of Q1 2021.
CSat Investment Advisory bought 6 Abiomed Inc shares in Q1 2021, an estimated $1.92K.
Abiomed Inc made up 0.05% of CSat Investment Advisory's portfolio in Q1 2021, its #145 holding.
CSat Investment Advisory first reported a position in Abiomed Inc in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's Abiomed Inc position peaked at $95K in Q3 2020.
487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.